Efficacy and safety of entecavir plus carnitine complex (GODEX®) compared to entecavir monotherapy in patient with ALT elevated chronic hepatitis B: randomized, multicenter open-label trials. The GOAL study-Reference-Cited by-同舟云学术

Efficacy and safety of entecavir plus carnitine complex (GODEX®) compared to entecavir monotherapy in patient with ALT elevated chronic hepatitis B: randomized, multicenter open-label trials. The GOAL study

Published:2013 Issue:2 Volume:19 Page:165
ISSN:2287-2728
Container-title:Clinical and Molecular Hepatology
language:en
Short-container-title:Clin Mol Hepatol

Author:

Jun Dae Won¹,Kim Byung Ik²,Cho Yong Kyun²,Kim Hong Ju²,Kwon Young Oh³,Park Soo Young³,Han Sang Young⁴,Baek Yang Hyun⁴,Jung Yong Jin⁵,Kim Hwi Young⁵,Kim Won⁵,Heo Jeong⁶,Woo Hyun Young⁶,Hwang Seong Gyu⁷,Rim Kyu Sung⁷,Choi Jong Young⁸,Bae Si Hyun⁸,Lee Young Sang⁹,Lim Young Suck⁹,Cheong Jae Youn¹⁰,Cho Sung Won¹⁰,Lee Byung Seok¹¹,Kim Seok Hyun¹¹,Sohn Joo Hyun¹²,Kim Tae Yeob¹²,Paik Yong Han¹³,Kim Ja Kyung¹³,Lee Kwan Sik¹³

Affiliation:

1. Department of Internal medicine, Hanyang University College of Medicine, Seoul, Korea.

2. Department of Internal Medicine, Kangbuk Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea.

3. Department of Internal Medicine, Kyungpook National University Hospital, Kyungpook National University College of Medicine, Daegu, Korea.

4. Department of Internal Medicine, Dong-A University Hospital, Dong-A University College of Medicine, Busan, Korea.

5. Department of Internal Medicine, SMG-SNU Boramae Medical Center, Seoul National University College of Medicine, Seoul, Korea.

6. Department of Internal Medicine, Pusan National University Hospital, Pusan National University College of Medicine, Busan, Korea.

7. Department of Internal Medicine, CHA Bundang Medical Center, CHA University College of Medicine, Seongnam, Korea.

8. Department of Internal Medicine, Seoul St. Mary's Hospital, The Catholic University of Korea College of Medicine, Seoul, Korea.

9. Department of Internal Medicine, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Korea.

10. Department of Internal medicine, Ajou University Hospital, Ajou University College of Medicine, Suwon, Korea.

11. Department of Internal Medicine, Chungnam National University College of Medicine, Daejeon, Korea.

12. Department of Internal Medicine, Hanyang University Guri Hospital, Hanyang University College of Medicine, Guri, Korea.

13. Department of Internal Medicine, Gangnam Severance Hospital, Yonsei University College of Medicine, Korea.

Publisher

The Korean Association for the Study of the Liver

Subject

Molecular Biology,Hepatology

Link

http://synapse.koreamed.org/pdf/10.3350/cmh.2013.19.2.165

Reference16 articles.

1. A Comparison of Entecavir and Lamivudine for HBeAg-Positive Chronic Hepatitis B

2. Partial virological response to entecavir in treatment-naive patients with chronic hepatitis B

3. Oral Godex Capsule for Chronic Liver Disease:A Double-blind, Randomized, Multicenter Controlled Trial

4. L-CARNITINE ALLEVIATES ALCOHOL-INDUCED LIVER DAMAGE IN RATS: ROLE OF TUMOUR NECROSIS FACTOR-ALPHA

Cited by 25 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Developments in small molecule antiviral drugs against hepatitis B and C viruses: FDA approved therapies and new drugs in clinical trials;Arabian Journal of Chemistry;2023-08

2. Prolonged Use of Carnitine-Orotate Complex (Godex®) Is Associated with Improved Mortality: A Nationwide Cohort Study;Journal of Personalized Medicine;2022-11-28

3. Effect of L-carnitine on quality of life in covert hepatic encephalopathy: a randomized, double-blind, placebo-controlled study;The Korean Journal of Internal Medicine;2022-07-01

4. Therapeutic mechanisms and beneficial effects of non-antidiabetic drugs in chronic liver diseases;Clinical and Molecular Hepatology;2022-07-01

5. Impact of l-Carnitine Supplementation on Liver Enzyme Normalization in Patients with Chronic Liver Disease: A Meta-Analysis of Randomized Trials;Journal of Personalized Medicine;2022-06-27